Breaking News
Get 45% Off 0
Investors lost 37% by missing this ONE signal 😵
Read now

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
Strategic Education (STRA) Q4 Earnings Beat, Margins High By Zacks Investment Research - Mar 01, 2020

Strategic Education, Inc. or SEI (NASDAQ:STRA) reported better-than-expected results in fourth-quarter 2019. The company’s earnings and revenues not only topped analysts’ expectations...

Top Ranked Momentum Stocks To Buy For March 2nd By Zacks Investment Research - Mar 01, 2020

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 2nd:Co-Diagnostics, Inc. (CODX): This molecular diagnostics company has a Zacks Rank #2...

Is CACI International Stock A Solid Choice Right Now? By Zacks Investment Research - Mar 01, 2020

One stock that might be an intriguing choice for investors right now is CACI International Inc. (NYSE:CACI) . This is because this security in the Computer – Services space is seeing solid...

Here's What To Note Ahead Of Abercrombie's (ANF) Q4 Earnings By Zacks Investment Research - Mar 01, 2020

Abercrombie & Fitch Co. (NYSE:ANF) is scheduled to report fourth-quarter fiscal 2019 results on Mar 4, before the opening bell. Notably, the company has a positive earnings surprise of 13.2% for...

5 Biotechs That Escaped The Coronavirus Onslaught Last Week By Zacks Investment Research - Mar 01, 2020

As the coronavirus uncertainty gripped the economy last week, the U.S. market witnessed probably its worst week since the 2008 financial crisis. The three major U.S. indices posted steep losses last...

Box (BOX) Q4 Earnings And Revenues Top Estimates, Rise Y/Y By Zacks Investment Research - Mar 01, 2020

Box, Inc. (NYSE:BOX) reported fiscal fourth-quarter 2020 earnings per share of 7 cents, which surpassed the Zacks Consensus Estimate by 3 cents. Moreover, the figure improved 22.5% year over...

Here's Why You Should Buy Edwards Lifesciences Stock Now By Zacks Investment Research - Mar 01, 2020

Edwards Lifesciences (NYSE:EW) has been progressing well with core segmental growth and acquisitions. The continued adoption of the INSPIRIS RESILIA aortic valve has been a key growth driver.In the...

Luminex Files For FDA 510(k) Clearance Of RSP Flex Assay By Zacks Investment Research - Mar 01, 2020

Luminex Corporation (NASDAQ:LMNX) recently submitted an application to the FDA, seeking a 510(k) clearance of the VERIGENE II Respiratory Flex Assay. It is the second VERIGENE II assay to be...

4 Top Stocks To Win Big From The Coronavirus Pandemic By Zacks Investment Research - Mar 01, 2020

Worries over how the coronavirus outbreak will impact corporate profit margins and global economy roiled the U.S. stock market in February. And it’s almost certain that the outbreak will...

Oxford Immunotec (OXFD) Reports Q4 Loss, Tops Revenue Estimates By Zacks Investment Research - Mar 01, 2020

Oxford Immunotec (OXFD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $1.25 per share a year ago. These figures...

Continue with Apple
Continue with Google
or
Sign up with Email